Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuropharmacology|January 1, 2008
Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independentEkaterina Boudanova, Deanna M Navaroli, Haley E Melikian
Molecular and Cellular Neurosciences|July 22, 2008
Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalizationEkaterina Boudanova, Deanna M Navaroli, Zachary Stevens, et al.
Protein Science : a Publication of the Protein Society|June 6, 2015
Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase AHuawei Qiu, Denise M Honey, Jonathan S Kingsbury, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Site-Specific Antibody Conjugation to Engineered Double Cysteine ResiduesQun Zhou, Josephine Kyazike, Ekaterina Boudanova, et al.
Mabs|June 15, 2019
Engineering an anti-CD52 antibody for enhanced deamidation stabilityHuawei Qiu, Ronnie Wei, Julie Jaworski, et al.
Mabs|June 21, 2019
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-lifeBrian C Mackness, Julie A Jaworski, Ekaterina Boudanova, et al.
Mabs|October 22, 2024
Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycanKaori Mukai, Robert Cost, Xin Sheen Zhang, et al.
Bioconjugate Chemistry|November 27, 2012
High-affinity VEGF antagonists by oligomerization of a minimal sequence VEGF-binding domainJames E Stefano, Julie Bird, Josephine Kyazike, et al.
Mabs|September 7, 2020
Engineered Fc-glycosylation switch to eliminate antibody effector functionQun Zhou, Julie Jaworski, Yanfeng Zhou, et al.
Bioconjugate Chemistry|January 29, 2013
Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of actionHuawei Qiu, Ekaterina Boudanova, Anna Park, et al.
Pageof 2